Beaune, France
May 14 - May 15, 2004
Assisted reproductive technologies include ovarian stimulation in the majority of cases. In recent years, experience accumulated in the treatment of infertile couples has led to the personalization of ovarian stimulation protocols. Every patient needs to be treated according to strategies developed with the help of basic science research devoted to a better understanding of ovarian physiology. In this light, this symposium covered both basic science and clinical experience.
The current knowledge on the basic aspects of follicle regulation and development was addressed as well as the perspectives of more recent discoveries. Furthermore, the progress made with the use of animal models, the genetic aspects of infertility, the possible influence of external substances, such as hormone disruptors on the ovarian function, and the main drugs used in ovarian stimulation was discussed.
The clinical section illustrated the protocols used outside IVF as well as the new stimulation regimens starting from the simplest ones, such as the natural cycle to the combination of gonadotrophins, GnRH agonists or antagonists. The specific problems of poor responders and PCO patients was addressed, as was the influence of ovarian stimulation in the luteal phase, on the endometrium, and the complications of stimulation regimens. A round table on how to conduct stimulation monitoring closed the meeting.
OBJECTIVES
After attending this symposium, the participants were able to identify:
- The regulation of follicle development;
- The main molecules used in ovarian stimulation;
- The stimulation regimens used in IVF and outside IVF;
- Ovarian stimulation strategies in difficult patients as poor responders or PCO;
- The effects of ovarian stimulation on the luteal phase and endometrium.
TARGET AUDIENCE
Clinicians and scientists, as well as biologists, involved in assisted reproduction or in ovarian function, benefited from the symposium.
This program “Regulation of Follicle Development and its Clinical Implications” has been submitted for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME).
EACCME credits are recognized by the American Medical Association towards Physician’s Recognition Award (PRA).
To convert EACCME credit to AMA PRA category 1 credit, contact the AMA.
CME accreditation for the symposium “Regulation of Follicle Development and its Clinical Implications” will be applied for from the Italian Ministry of Health.
